Thursday, May 23, 2019

Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'

A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?

from Featured Health News from Medical News Today http://bit.ly/2VKK2uy

No comments:

Post a Comment

Scientists say most people need more protein than current guidelines suggest

A new review suggests that doing more exercise and eating more protein than current minimum recommendations may help people stay stronger, s...